OpenAI released GPT-Rosalind, a reasoning model specifically tuned for life sciences research. The tool accelerates the transition from hypothesis to experimental design. Access remains tightly controlled during this initial phase. This specialized focus allows biologists to automate complex reasoning tasks without relying on general-purpose models that lack domain-specific precision.